Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis

Clinical trial NCT00348296 · COMPLETED

Trial details

NCT number: NCT00348296
Sponsor: Benesis Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Scleroderma, Systemic

Start date: 2006-07-01
Primary completion: 2009-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.